Treatment of nasolacrimal duct obstruction

The effect of intubation in dacteriucyctorinostomy in patient with primary acquired nasolacrimal duct obstruction trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201205216388N2

Enrollment

Registered

2012-06-02

Start date

2012-07-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary acquire nasolacrimal duct obstruction. Acute and unspecified inflammation of lacrimal passages

Interventions

Intervention 1: External dacteriucyctrinostomy with intubation. Intervention 2: External dacteriucyctrinostomy without intubation.

Treatment - Surgery

External dacteriucyctrinostomy with intubation

External dacteriucyctrinostomy without intubation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patient with primary acquire nasolacrimal duct obstruction Exclusion criteria: History of surgery on nasolacrimal duct, Secondary obstruction in nasolacrimal duct

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
The degree of nasolacrimal duct obstruction. Timepoint: Every 6 weeks. Method of measurement: MUNK scoring system.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactRambod Saburihamed

Tabriz University Of Medical Sciences

rambod.sabouri.@gmail.com ; amirk_nba@yahoo.com+98 41 1558 5789

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026